Deciphering the pathogen heterogeneity for precise diagnosis and personalized therapeutics of infections after kidney transplantation: insights from metagenomic next-generation sequencing
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1456407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Xin Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Kidney Transplantation, High-Throughput Nucleotide Sequencing, Precision Medicine, Metagenomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The aim of this study was to compare the detection performance of mNGS against that of conventional tests (CT) in patients suffering from infection after kidney transplantation.
Methods
A total of 138 samples from 85 kidney transplant patients with acute or chronic infections were simultaneously analyzed using mNGS and CT from July 2021 to August 2023.
Results
Compared with CT, mNGS demonstrated a higher sensitivity (95.96% vs. 27.27%) but lower specificity (48.72% vs. 84.62%) in pathogen detection. Moreover, mNGS exhibited significant advantages in detecting mixed and rare infections. The pathogens commonly identified in kidney transplant patients were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), followed by Pneumocystis jirovecii and Cytomegalovirus (CMV). mNGS guided the precise clinical diagnosis in 89.13% of cases and assisted in altering therapeutics from empirical antibiotic approaches to personalized plans in 56.10% of cases, including treatment escalation (40.65%), initiation (11.38%), drug adjustment (3.25%), and de-escalation (0.81%).
Discussion
Our study demonstrated the superior detection performance of mNGS and its significant clinical value. This reflected the great potential of mNGS as a complementary clinical detection technology for kidney transplant patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Medicine, Dinfectome Inc., Nanjing, China.
Zitieren
APA
Ye, X., Lin, Y., Yang, J., Qi, B., Wei, X., Huang, Y., & Wang, L. (2024). Deciphering the pathogen heterogeneity for precise diagnosis and personalized therapeutics of infections after kidney transplantation: insights from metagenomic next-generation sequencing. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1456407
Vancouver
Ye X, Lin Y, Yang J, Qi B, Wei X, Huang Y, et al. Deciphering the pathogen heterogeneity for precise diagnosis and personalized therapeutics of infections after kidney transplantation: insights from metagenomic next-generation sequencing. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1456407
BibTeX
@article{Ye2024,
author = {Ye, Xin and Lin, Yuxin and Yang, Jiangnan and Qi, Baocui and Wei, Xuedong and Huang, Yuhua and Wang, Liangliang},
title = {Deciphering the pathogen heterogeneity for precise diagnosis and personalized therapeutics of infections after kidney transplantation: insights from metagenomic next-generation sequencing},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1456407}
}
EUVIMED